Posts Tagged Akili
Pharma’s digital inflection point
Posted by Dominic Tyer in digital transformation, Health and Pharma on March 12, 2022
Billed as the world’s most influential technology event, this year’s CES show saw its first ever keynote from a healthcare company when Abbott CEO Robert Ford took to the stage in Las Vegas in January.
For Ford, the focus was on his company’s new range of consumer ‘biowearable’ health devices, but his appearance was also another reminder of the increasing importance of ‘digital’ in all its forms across the life sciences sector.
Alongside buzzworthy metaverse, NFT and cryptocurrency offerings, this year’s CES also saw updates in remote patient monitoring tech, mobile games for better mental health and a slew of wellness devices.
Read the rest of this entry »